IL10RA and hepatocellular carcinoma: In studies investigating the treatment of HCV infection and HCC, researchers have constructed the recombinant plasmid pcCD19scFv-IL10R to target mouse B10 cells and enhance the anti-HCV immune response or inhibit HCC growth in vivo (165, 166).